
Demarest Advogados’ life sciences practice was recently strengthened with the appointment of new practice head Elysangela Rabelo, who joined from Rabelo Law. Rabelo brings extensive experience in regulatory matters and commercial transactions within the life sciences and healthcare sectors, and regularly advises clients on public-private partnerships (PPPs). The practice is adept at advising clients on safety, quality, and regulatory standards, offering counsel on licensing and regulatory issues. Public law specialist Bruno Aurélio co-leads the practice, assisting tobacco, pharmaceutical, and healthcare clients with administrative processes and public law cases. Co-lead Claudio Mattos focuses on regulatory matters for pharmaceuticals and bio-controlled substances, disputes involving genetically modified organisms, and contractual issues. Camila Biral is the go-to lawyer for pharmaceutical and biotechnology clients involved in liability disputes. Nicole Aun, who has extensive experience in biotechnology, bioinputs, contracts, digital health, M&A and corporate structuring, joined from Pinheiro Neto Advogados in August 2025.
\n
\n
Legal 500 redaktioneller Kommentar
Anwält*innen
Leading partners
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Next Generation Partners
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Nicole Aun
Praxisleitung
Elysangela Rabelo; Bruno Aurélio; Claudio Mattos
Weitere Kernanwält*innen
Camila Biral; Tatiana Campello; Giulio Gatti; Nicole Aun
